Lidocaine Infusion for Propofol Dose Reduction in ERCP Procedure

Phase 1 Unknown 100 enrolled Iuliu Hatieganu University of Medicine and Pharmacy

RandomizedParallel-groupTriple-blindTreatment

Summary

This study aims to investigate the dose reduction of propofol if associated with continuous infusion of lidocaine during ERCP procedures in patients over 65 years old.

Timeline

Start: 2022-01-03
Primary completion: 2022-03-03
Completion: 2022-04-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Lidocaine	Other / unclassified	2 mg/kg	—

Indications

No indication recorded.